
BeOne is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 10,000 colleagues spans five continents, with administrative offices in Basel, Beijing, and Cambridge, U.S. To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn and X (formerly known as Twitter).
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
The Manager/Senior Manager, Material Review Governance & Operation, is responsible for the governance, oversight, and enhancing of BeOne Medicines Japan’s promotional and medical material review processes to ensure compliance with applicable regulations, industry codes, company policies, and scientific standards. Reporting to the Director of Medical Operations Japan, in the Medical Affairs organization, this position is the cornerstone of BeOne’s Medical-Legal-Regulatory (MLR) review framework and is accountable for maintaining robust governance for promotional and medical material review processes. The role oversees first-level, outsourced reviewers, evaluates and manages their performance, signs off on the reviewed materials for use, as well as resolving conflicts as they arise working with multi-functional stakeholders, such as Medical Affairs, Legal, Regulatory Affairs, Compliance, and business stakeholders to ensure compliant and effective dissemination of product and disease-related information.
The position also is a critical part of the Promotional Material Review Supervisory Function and serves as secretariat to the Promotional Material Review Oversight Committee, ensuring appropriate risk management, decision-making, documentation, and continuous process improvement across review operations.
Minimum of B.S. or equivalent education
Master’s Degree is preferred
What We Offer To Our Valued Employees
BeOne Global Competencies
When we exhibit our values of Patients First, Collaborative Spirit, Bold Ingenuity and Driving Excellence, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.
BeOne is committed to respect and protect personal information rights of job applicants and will process job applicants’ personal information in accordance with applicable laws and regulations.
Due to BeOne’s global operation, job applicants’ data will be stored overseas with adequate protection. Besides, job applicants’ data will be stored for no longer than is necessary to facilitate potential application for other suitable positions in BeOne. For further details, please refer to BeOne’s Job Applicant Privacy Policy (https://beonemedicines.com/privacy-policy).
If you voluntarily provide your personal information to us, it is deemed as you have acknowledged and consented to (if required by the applicable laws) BeOne’s Job Applicant Privacy Policy as well as the relevant privacy terms. If you voluntarily provide the personal information of other job applicants to us, it is deemed as you have ensured that the relevant individuals have acknowledged and consented to (if required by the applicable laws) BeOne’s Job Applicant Privacy Policy as well as the relevant privacy terms.
If you have any concern, please DO NOT provide any resume or other personal information to us.

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible.
To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.